Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jon Oxley

Showing results (31-40 of 62) with videos related to

Pageof 7
Sort By:
Cancers|January 28, 2026
Correction: Kingshott et al. Alteration of Metabolic Conditions Impacts the Regulation of IGF-II/H19 Imprinting Status in Prostate Cancer. <i>Cancers</i> 2021, <i>13</i>, 825Georgina Kingshott, Kalina Biernacka, Alex Sewell, et al.
Cancers|March 6, 2021
Alteration of Metabolic Conditions Impacts the Regulation of IGF-II/H19 Imprinting Status in Prostate CancerGeorgina Kingshott, Kalina Biernacka, Alex Sewell, et al.
Trials|March 8, 2016
Prostate cancer - evidence of exercise and nutrition trial (PrEvENT): study protocol for a randomised controlled feasibility trialLucy Hackshaw-McGeagh, J Athene Lane, Raj Persad, et al.
Pilot and Feasibility Studies|August 12, 2022
Prostate cancer-Exercise and Metformin Trial (Pre-EMpT): study protocol for a feasibility factorial randomized controlled trial in men with localised or locally advanced prostate cancerLucy McGeagh, Luke A Robles, Raj Persad, et al.
BJU International|March 28, 2026
Long-term outcomes of cribriform-positive and cribriform-negative prostate cancer treated with radical prostatectomy in the ProtecT trialNikita Sushentsev, Anne Y Warren, Richard Colling, et al.
BJU International|November 18, 2020
Prostate cancer grading, time to go back to the futureLars Egevad, Brett Delahunt, David G Bostwick, et al.
BJU International|September 28, 2020
NeuroSAFE frozen section during robot-assisted radical prostatectomy: peri-operative and histopathological outcomes from the NeuroSAFE PROOF feasibility randomized controlled trialEoin Dinneen, Aiman Haider, Jack Grierson, et al.
Histopathology|September 19, 2014
Gleason drift in the NIHR ProtecT studyJon Oxley, Andrew Simpkin, John Goepel, et al.
Histopathology|November 29, 2024
Unexpectedly high variability in determining tumour extent in prostatic biopsies: implications for active surveillanceMarit Bernhardt, Leonie Weinhold, Felix Bremmer, et al.
Histopathology|March 9, 2025
Interobserver reproducibility of a hybrid three-tier grading system of papillary nonmuscle invasive urothelial carcinoma: an international Uropathology studyMichelle R Downes, Katherine Lajkosz, Ferran Algaba, et al.
Pageof 7

Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
Cancers|January 28, 2026
Correction: Kingshott et al. Alteration of Metabolic Conditions Impacts the Regulation of IGF-II/H19 Imprinting Status in Prostate Cancer. <i>Cancers</i> 2021, <i>13</i>, 825Georgina Kingshott, Kalina Biernacka, Alex Sewell, et al.
Cancers|March 6, 2021
Alteration of Metabolic Conditions Impacts the Regulation of IGF-II/H19 Imprinting Status in Prostate CancerGeorgina Kingshott, Kalina Biernacka, Alex Sewell, et al.
Trials|March 8, 2016
Prostate cancer - evidence of exercise and nutrition trial (PrEvENT): study protocol for a randomised controlled feasibility trialLucy Hackshaw-McGeagh, J Athene Lane, Raj Persad, et al.
Pilot and Feasibility Studies|August 12, 2022
Prostate cancer-Exercise and Metformin Trial (Pre-EMpT): study protocol for a feasibility factorial randomized controlled trial in men with localised or locally advanced prostate cancerLucy McGeagh, Luke A Robles, Raj Persad, et al.
BJU International|March 28, 2026
Long-term outcomes of cribriform-positive and cribriform-negative prostate cancer treated with radical prostatectomy in the ProtecT trialNikita Sushentsev, Anne Y Warren, Richard Colling, et al.
BJU International|November 18, 2020
Prostate cancer grading, time to go back to the futureLars Egevad, Brett Delahunt, David G Bostwick, et al.
BJU International|September 28, 2020
NeuroSAFE frozen section during robot-assisted radical prostatectomy: peri-operative and histopathological outcomes from the NeuroSAFE PROOF feasibility randomized controlled trialEoin Dinneen, Aiman Haider, Jack Grierson, et al.
Histopathology|September 19, 2014
Gleason drift in the NIHR ProtecT studyJon Oxley, Andrew Simpkin, John Goepel, et al.
Histopathology|November 29, 2024
Unexpectedly high variability in determining tumour extent in prostatic biopsies: implications for active surveillanceMarit Bernhardt, Leonie Weinhold, Felix Bremmer, et al.
Histopathology|March 9, 2025
Interobserver reproducibility of a hybrid three-tier grading system of papillary nonmuscle invasive urothelial carcinoma: an international Uropathology studyMichelle R Downes, Katherine Lajkosz, Ferran Algaba, et al.
Pageof 7